Pfizer and BioNTech say their COVID-19 vaccine induced a robust immune response in five- to 11-year-olds.
— CBC News (@CBCNews) September 20, 2021
They plan to ask for authorization to use the vaccine in children in that age range in the U.S., Europe and elsewhere as soon as possible. https://t.co/UVnWetg4WM